The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
A major highlight of the event was the launch of several publications and digital initiatives, including a certification course on the Ayush Grid portal
The trial also demonstrated significant improvements across multiple secondary endpoints
Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings
Move aligns global biologics identity under the Biocon Biologics brand
Industry, policymakers focus on AI-led regulatory harmonisation, FTAs, MSME support and market expansion as exports touch $28.29 billion till February FY26
Empowering 15 Women in STEM (Life Sciences) with scholarship, internship and mentorship
18-year veteran Saharsh will position the CDMO as a premier global API process development and commercial manufacturing specialist
The impact on Phase III trials is particularly significant, as these later-stage studies involve larger, committed patient populations and represent years of investment
The decision is based on the phase 3 DESTINY-Breast11 trial
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
